Dr. Landovitz joined the UCLA CARE Center in 2006 after training at Harvard Medical School, Brigham and Women's Hospital, and Massachusetts General Hospital. He also served as medical co-director for the Vietnam CDC Harvard Medical School AIDS Partnership in Ho Chi Minh City, Vietnam. He is an infectious disease and HIV clinician with both a clinical and research interest in HIV prevention, particularly the use of chemoprophylaxis as part of HIV prevention - PrEP, PEP, and microbicides. He additionally studies the impact of such prevention interventions on risk behavior. He works in the ACTG, HPTN and ATN clinical trials networks. He was awarded the John Carey Young Investigator Award by the ACTG in June 2010, and the HIVMAA HIV research award in 2017. He leads the NIH-funded effort to develop long-acting injectable PrEP and lectures and teaches internationally on HIV Prevention, including pre-and post-exposure prophylaxis.
Medical Board Certification
- HIV Prevention (including PEP, PrEP and other combination prevention strategies)
- HIV and STD diagnosis and treatment
- Top Doctors, Los Angeles Magazine, 2021